Online Finance for Growth course

Expand your knowledge on Finance & Valuation in Life Sciences & Health

Understanding financial concepts and business valuation is of critical importance in Life Sciences & Health. Whether you are an entrepreneur seeking funding for your start-up, a tech transfer officer, a business analyst, consultant or policy advisor who needs to thoroughly evaluate business proposals and business cases, this in-depth crash course will increase your understanding and expand your knowledge as a non-financial on financing and valuating companies in Life Sciences & Health.

This course is organised by Vrije Universiteit Amsterdam. Based upon real case studies within the Life Sciences & Health sector you will learn the ins and outs of the fundamentals of strategic financing, the theory and practise of valuation and practical aspects of incorporation.

Participant Profile

> Founders of biotech companies
> Tech Transfer Officers
> Investment Analysts
> Policy makers
> Consultants 

Program covering:

> Financial statement analysis
> Making a convincing business case
> Financial feasibility: calculations & valuation
> Negotiating & VC deal terms
> The time value of money and capital budgeting
> Scaling up: financial requirements and best practices
> Securing an exit: the role of investment bankers

benefits of the virtual format

> Synchronous online seminars with experts from the field
> Review slidecast at your own pace, learn anywhere at any time, around your existing commitments 
> Work on assignments with fellow participants 
> Frequent interaction with faculty, guest speakers and peers 
> Immersive and interactive learning experience from the safety of your own home


 When Module Content 
 26 Oct - 3 Nov 2020 1. The basics of strategic finance: financial statement analysis
  • What to learn form financial statements? The basics of reading and interpreting balance sheets, profit and loss statements and cash flow statement.
 29 Oct - 6 Nov 2020 2. Starting from scatch: what makes a convincing business case
  • How do non-dilutive funding organizations and venture capitalists evaluate companies before they invest? Experiences from a seasoned investor and an experienced business coach.
 6 - 17 Nov 2020 3. Financial feasibility: smart calculations and valuation of biotech companies
  • Conducting smart calculations with a common spreadsheet tool: advanced use of Excel functions
 12 - 20 Nov 2020 4. Negotiating and implementing a deal: venture capital deal terms and optimizing your fiscal position
  • The most often used venture capital deal terms and the most overlooked clauses. And the practical, fiscal and accountancy aspects of incorporation and financing in the Life Sciences.
 20 Nov - 1 Dec 2020 5. Understanding investments: the time value of money and capital budgeting
  • Why the profits in pharma need to be high, and how to calculate this.
 26 Nov - 4 Dec 2020 6. Scaling up: financial requirements and best practices
  • The role of budget impact and incremental cost-effectiveness
 4 - 15 Dec 2020 7. Negotiating a deal: how much is my company worth?
  • Applying different techniques to valuate companies and to evaluate whether investing in a project is financially interesting
 10 - 18 Dec 2020  8. Securing an exit: the role of investment bankers
  •  How to conduct financial calculations for the Life Sciences: industry specific costs, revenues, margins and risk profiling, and perspectives of seasoned investors and investment bankers on valuation of deals

Program Director

Eric Claassen, Professor Business Management & Entrepreneurship in Health & Life Sciences at Vrije Universiteit Amsterdam

faculty/speakers 2020

> Bart Bergstein, Board member of various life sciences companies
> Arjan Bisseling, Owner of AsjesBisseling Belastingadviseurs
> Eric Claassen, Professor in Business Management & Entrepreneurship in Health & Life Sciences
> Matteo Milone, Assistant Professor Finance
> Yves Prevoo, Founder & CEO of Easee
> Arjen Siegmann, Associate Professor in Finance
> Harm de Vries, General Partner at Innovation Industries
> Judith Smit, Managing Partner at FFUND
> Karin Bergstein, CFO at Aidence and non-executive board member within life sciences sector
> Frederik Gorter de Vries, Director Corporate Finance Life Sciences & Healthcare at Kempen & Co


> Apply soon as places are limited!
> Standard fee for the course: €1,450
> Deadline of registration is 16 October 2020
All prices are excl. VAT.

ECTS credited
The course has a study load of 6 ECTS (168 hours). You will receive a certificate of attendance after finalizing the course.


Click here to register for this course.

Download the brochure

More info

If you have questions about the program, please contact Dr. Linda van de Burgwal of the VU University at If you have questions about the registration and invoice, please contact us at


Join the community of BDP Life Sciences of Business Development professionals and Business leaders in Life Sciences & Health. Through our programmes you will connect with fellow participants, our speakers, coaches and alumni. Also connect with us online via LinkedIn.


Contribute to the development of future business leaders in Life Sciences & Health by becoming a speaker, mentor or sponsor of our programmes. Contact us to discuss the possibilities via info[at] 


Are you looking for a Business Development professional? Our partner PRIMER BioBusiness is specialised in the recruitment of commercial talent for the Life Sciences. Whether you need new talent, experienced professional ar an executive to lead your company, contact us to start your search.